67 research outputs found
Recommended from our members
The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction.
The practice of ovarian stimulation for IVF is undergoing a fundamental re-evaluation as recent data begin to successfully challenge the traditional paradigm that ovarian stimulation should be aimed at the retrieval of as many oocytes as possible, in the belief that this will increase pregnancy rates. An opposing view is that live birth rate should not be the only end-point in evaluating the success of IVF treatment and that equal emphasis should be placed on safety and affordability. The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) committee has carried out an up-to-date literature search, with the evidence being graded according to the University of Oxford's Centre for Evidence-Based Medicine. The recommendations were formulated taking into account the quality of evidence on the efficacy, risk and cost of each intervention. ISMAAR recommends adopting a mild approach to ovarian stimulation in all clinical settings as an increasing body of evidence suggests that mild stimulation is as effective as conventional stimulation, while being safer and less expensive. Mild ovarian stimulation could replace conventional stimulation, thus making IVF safer and more accessible worldwide
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen
characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose
and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male
infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect
fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and
DNA, which may impair the sperm’s potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of
male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress
Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many
patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a
useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants
(antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the
potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective
test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing
the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis,
future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause
Standards in semen examination:publishing reproducible and reliable data based on high-quality methodology
Biomedical science is rapidly developing in terms of more transparency, openness and reproducibility of scientific publications. This is even more important for all studies that are based on results from basic semen examination. Recently two concordant documents have been published: the 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, and the International Standard ISO 23162:2021. With these tools, we propose that authors should be instructed to follow these laboratory methods in order to publish studies in peer-reviewed journals, preferable by using a checklist as suggested in an Appendix to this article.Peer reviewe
Evidence-based recommendations for IUI in daily practice
It is generally accepted that intrauterine insemination (IUI) with homologous semen should be preferred as a first choice treatment to more invasive and expensive techniques of assisted reproduction in the case of cervical, unexplained and moderate male factor subfertility. Scientific validation of this strategy is difficult because the literature is rather confusing and not conclusive. The rationale for the use of artificial insemination is to increase gamete density at the site of fertilization. Many variables may influence success rates after IUI treatment procedures. It’s obvious that some factors will never be solved by methodological adjustments such as female age, duration of infertility etc. However, quite a number of variables can be improved upon using different strategies.
In this paper we will make a review of recommendations for daily IUI practice based on evidence-based data
DEBATE- The current role of intrauterine insemination for the treatment of male factor and unexplained infertility
Related Articles: mf05003,mf05004,mf05005, and mf0500
What does a clinically-scientific professional society stand for?
Originated as a mainly social group of befriended colleagues, the VVOG has evolved over the past 55 years to become a truly professional society facing successfully such diverse challenges as organizing scientific congresses, postgraduate training, ethical debates, hands-on training courses, social events, interactions with national and international sister societies but also with the industry, insurers, the government, politicians and patient organisations
- …